Anna V. Smolyannikova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna V. Smolyannikova has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Andrey Yu. Emelin
Kirov Military Medical Academy, St. Petersburg, Russia
2 shared publications - Igor’ Vyacheslavovich Litvinenko
S.M. Kirov Military Medical Academy
2 shared publications - Vladimir Yuryevich Lobzin
S.M. Kirov Military Medical Academy
2 shared publications - D. N. Frunza
S.M. Kirov Military Medical Academy
1 shared publication - Gaspar V. Gavrilov
Pavlov First St. Petersburg State Medical University
1 shared publication - Kristina A. Kolmakova
S.M. Kirov Military Medical Academy
1 shared publication
Latest Publications
- Open Access
- 5 November 2025
- Published by ECO-Vector LLC (Publications) in Russian Military Medical Academy Reports
- Vol. 44 (4) , 445-454
Comorbidity and differential diagnosis of idiopathic normal pressure hydrocephalus and Alzheimer disease
BACKGROUND: The progression of intellectual and memory impairment is a pressing public health challenge and often leads to disability in older adults. Idiopathic normal pressure hydrocephalus represents one of the causes of dementia and is frequently comorbid with neurodegenerative disorders, particularly Alzheimer disease. Such comorbidity substantially complicates differential diagnosis. Therefore, the search of diagnostic algorithms that allow clinicians to address this problem is essential. AIM: This work aimed to improve the diagnostic accuracy of idiopathic normal pressure hydrocephalus, Alzheimer disease, and their combination by applying a comprehensive clinical, neuropsychological, laboratory, and neuroimaging assessment. METHODS: All patients (171 individuals) were divided into groups according to the disease. All subjects underwent extended neuropsychological testing, gait assessment using standardized scales, neuroimaging interpretation using neuroradiological scales, and cerebrospinal fluid biomarker assay of amyloidogenic and tau-pathology–related proteins. RESULTS: Patients with normal pressure hydrocephalus demonstrated a predominantly dysregulatory cognitive impairment pattern, whereas memory impairment was secondary. In the combined Alzheimer disease–idiopathic normal pressure hydrocephalus syndrome, both dysregulatory and amnestic patterns coexisted (with the amnestic component predominating). Markedly reduced gait speed was a highly sensitive marker of idiopathic normal pressure hydrocephalus. Patients with the comorbidity also demonstrated reduced gait speed, although to a lesser degree. Cerebrospinal fluid biomarker profile in normal pressure hydrocephalus was characterized by reduced tau and phosphorylated tau levels with normal β-amyloid. In contrast, comorbid patients demonstrated reduced β-amyloid and increased tau and phosphorylated tau concentrations. Neuroimaging analysis revealed that idiopathic normal pressure hydrocephalus is characterized by pronounced ventricular enlargement in the absence of substantial cortical atrophy. Typical features include an acute callosal angle, elevated Evans Index and Z-Evans Index, and a 1.0 brain-to-ventricle ratio. In combined Alzheimer disease–idiopathic normal pressure hydrocephalus syndrome, the neuroimaging pattern integrates the features of both diseases. The severity of cortical atrophy assessed using the medial temporal lobe atrophy scale and Koedam scale is closely associated with cerebrospinal fluid biomarker alterations. Key diagnostic features were identified that allow the clinician to suspect the combined Alzheimer disease–idiopathic normal pressure hydrocephalus syndrome. CONCLUSION: Identification of specific cognitive impairment, gait speed reduction, characteristic neuroimaging findings, and cerebrospinal fluid biomarker profile as part of comprehensive diagnostic approach enables timely and clear differential diagnosis between idiopathic normal pressure hydrocephalus, Alzheimer disease, and their combination.
- 5 November 2025
- Published by ECO-Vector LLC (Publications) in Russian Military Medical Academy Reports
- Vol. 44 (4) , 445-454
Open AccessComorbidity and differential diagnosis of idiopathic normal pressure hydrocephalus and Alzheimer disease
BACKGROUND: The progression of intellectual and memory impairment is a pressing public health challenge and often leads to disability in older adults. Idiopathic normal pressure hydrocephalus represents one of the causes of dementia and is frequently comorbid with neurodegenerative disorders, particularly Alzheimer disease. Such comorbidity substantially complicates differential diagnosis. Therefore, the search of diagnostic algorithms that allow clinicians to address this problem is essential. AIM: This work aimed to improve the diagnostic accuracy of idiopathic normal pressure hydrocephalus, Alzheimer disease, and their combination by applying a comprehensive clinical, neuropsychological, laboratory, and neuroimaging assessment. METHODS: All patients (171 individuals) were divided into groups according to the disease. All subjects underwent extended neuropsychological testing, gait assessment using standardized scales, neuroimaging interpretation using neuroradiological scales, and cerebrospinal fluid biomarker assay of amyloidogenic and tau-pathology–related proteins. RESULTS: Patients with normal pressure hydrocephalus demonstrated a predominantly dysregulatory cognitive impairment pattern, whereas memory impairment was secondary. In the combined Alzheimer disease–idiopathic normal pressure hydrocephalus syndrome, both dysregulatory and amnestic patterns coexisted (with the amnestic component predominating). Markedly reduced gait speed was a highly sensitive marker of idiopathic normal pressure hydrocephalus. Patients with the comorbidity also demonstrated reduced gait speed, although to a lesser degree. Cerebrospinal fluid biomarker profile in normal pressure hydrocephalus was characterized by reduced tau and phosphorylated tau levels with normal β-amyloid. In contrast, comorbid patients demonstrated reduced β-amyloid and increased tau and phosphorylated tau concentrations. Neuroimaging analysis revealed that idiopathic normal pressure hydrocephalus is characterized by pronounced ventricular enlargement in the absence of substantial cortical atrophy. Typical features include an acute callosal angle, elevated Evans Index and Z-Evans Index, and a 1.0 brain-to-ventricle ratio. In combined Alzheimer disease–idiopathic normal pressure hydrocephalus syndrome, the neuroimaging pattern integrates the features of both diseases. The severity of cortical atrophy assessed using the medial temporal lobe atrophy scale and Koedam scale is closely associated with cerebrospinal fluid biomarker alterations. Key diagnostic features were identified that allow the clinician to suspect the combined Alzheimer disease–idiopathic normal pressure hydrocephalus syndrome. CONCLUSION: Identification of specific cognitive impairment, gait speed reduction, characteristic neuroimaging findings, and cerebrospinal fluid biomarker profile as part of comprehensive diagnostic approach enables timely and clear differential diagnosis between idiopathic normal pressure hydrocephalus, Alzheimer disease, and their combination.
- Open Access
- 11 January 2023
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 27 (6) , 70-76
Тhe clinical case of benign monomelic amyotrophy of the lower limb
The benign monomelic amyotrophy of the lower limb is a slowly progressive disease that is clinically manifested by muscle atrophy in only one lower limb. This disease is quite rare, while it is most common in Asian countries (about 80 cases have been described). According to the literature a total of 16 cases of benign monomelic amyotrophy of the lower limb were described in Europe by 2000. Etiology and pathogenesis have not been reliably studied now. The article presents a clinical case of the development of this disease in a 42-year-old patient. The patient was admitted with complaints of weakness in the right leg and its decrease in volume. During the period of hospitalization, diff erential diagnosis was carried out with amyotrophic lateral sclerosis, progressive muscle atrophy, Hirayama disease, vascular and paraneoplastic processes. According to the results of a comprehensive laboratory and instrumental examination, the diagnosis was fi rst established: benign monomelic amyotrophy of the lower limb. The father of a patient who had atrophy of the muscles of the left lower limb would also be examined. According to the data of hereditary anamnesis, an assumption was made about the presence of the phenomenon of anticipation in the inheritance of benign monomelic amyotrophy of the lower limb. This article describes for the fi rst time a case of benign monomelic amyotrophy of the lower limb in the domestic literature, as well as a familial case of this disease all over the world.
- 11 January 2023
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 27 (6) , 70-76
Open AccessТhe clinical case of benign monomelic amyotrophy of the lower limb
The benign monomelic amyotrophy of the lower limb is a slowly progressive disease that is clinically manifested by muscle atrophy in only one lower limb. This disease is quite rare, while it is most common in Asian countries (about 80 cases have been described). According to the literature a total of 16 cases of benign monomelic amyotrophy of the lower limb were described in Europe by 2000. Etiology and pathogenesis have not been reliably studied now. The article presents a clinical case of the development of this disease in a 42-year-old patient. The patient was admitted with complaints of weakness in the right leg and its decrease in volume. During the period of hospitalization, diff erential diagnosis was carried out with amyotrophic lateral sclerosis, progressive muscle atrophy, Hirayama disease, vascular and paraneoplastic processes. According to the results of a comprehensive laboratory and instrumental examination, the diagnosis was fi rst established: benign monomelic amyotrophy of the lower limb. The father of a patient who had atrophy of the muscles of the left lower limb would also be examined. According to the data of hereditary anamnesis, an assumption was made about the presence of the phenomenon of anticipation in the inheritance of benign monomelic amyotrophy of the lower limb. This article describes for the fi rst time a case of benign monomelic amyotrophy of the lower limb in the domestic literature, as well as a familial case of this disease all over the world.